- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
IRF5 gene polymorphisms in melanoma ; volume:10 ; number:1 ; day:21 ; month:8 ; year:2012 ; pages:1-8 ; date:12.2012
Journal of translational medicine ; 10, Heft 1 (21.8.2012), 1-8, 12.2012
- Creator
-
Uccellini, Lorenzo
- Contributor
-
De Giorgi, Valeria
Zhao, Yingdong
Tumaini, Barbara
Erdenebileg, Narnygerel
Dudley, Mark E.
Tomei, Sara
Bedognetti, Davide
Ascierto, Maria Libera
Liu, Qiuzhen
Simon, Richard
Kottyan, Leah
Kaufman, Kenneth M.
Harley, John B.
Wang, Ena
Rosenberg, Steven A.
Marincola, Francesco M.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-170
- URN
-
urn:nbn:de:1111-2016041442157
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Uccellini, Lorenzo
- De Giorgi, Valeria
- Zhao, Yingdong
- Tumaini, Barbara
- Erdenebileg, Narnygerel
- Dudley, Mark E.
- Tomei, Sara
- Bedognetti, Davide
- Ascierto, Maria Libera
- Liu, Qiuzhen
- Simon, Richard
- Kottyan, Leah
- Kaufman, Kenneth M.
- Harley, John B.
- Wang, Ena
- Rosenberg, Steven A.
- Marincola, Francesco M.
- SpringerLink (Online service)
Other Objects (12)
RNA amplification for successful gene profiling analysis
Translational medicine from observation to hypothesis to interpretation
Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling
Changing paradigm through a genome-based approach to clinical and basic immunology
The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Translational Medicine is developing in China: A new venue for collaboration
Melanoma-restricted genes
MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Potency analysis of cellular therapies: the emerging role of molecular assays
Ovarian cancer, the coagulation pathway, and inflammation
RNA amplification for successful gene profiling analysis
Translational medicine from observation to hypothesis to interpretation
Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling
Changing paradigm through a genome-based approach to clinical and basic immunology
The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Translational Medicine is developing in China: A new venue for collaboration
Melanoma-restricted genes
MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Potency analysis of cellular therapies: the emerging role of molecular assays
Ovarian cancer, the coagulation pathway, and inflammation
RNA amplification for successful gene profiling analysis
Translational medicine from observation to hypothesis to interpretation
Polymorphism in clinical immunology – From HLA typing to immunogenetic profiling
Changing paradigm through a genome-based approach to clinical and basic immunology
The challenge of studying complex diseases undergoing complex treatments: the metastatic cancer model
TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines
Translational Medicine is developing in China: A new venue for collaboration
Melanoma-restricted genes
MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells
Peritoneal inflammation – A microenvironment for Epithelial Ovarian Cancer (EOC)
Potency analysis of cellular therapies: the emerging role of molecular assays